Member Info for Pacman121

@MF You should prob ask Guy that one, he likes to keep tabs on everyone elses posts inc dates and times etc. Not sure if he also has a tally for repetition.

Just so we all remember there is revenue (some are making out there is none):

"HCV is a chronic disease. You can have it for 15 years and not have any symptoms at all," said Budd. "When the world was focusing on COVID, chronic disease was left to the side," he said.

Despite this temporary setback, Budd said sales have resumed in Africa and Asia Pacific, which he described as the primary markets for the test. "We see more activity picking up, and I think we can feel positive that it's turned around," he said.

Only test on market. Projected figure wasn't made up by me. You can engage me if you like but you'll look more of a D1(k than you do already. Nothing statement after nothing statement. Take £500 to a therapist and get them to help you pump the hate breaks and give us all a rest.

Jace, market needs sellers. Maybe time to take one for the team?

First time since Indian imports licence (1065 trades that day) that it's been NT to buy in volume. Hopefully it'll pick up as today's conference results go mainstream. £30-£50m a year projection don't forget.

Say something else Jace, anything, just for variation.

hahaha but we wouldn't get any new news with Jace. We would just get the same thing repeated over and over and over lol. People would need therapy.

BIG BIG market in the US as well to avoid law suits. NHS been working really closely with all groups involved in the test and I remember those from a clinical/medical background that were drowned out here when trying to discuss the AIHL test, all seemed keen.

Looks like they are ahead of schedule on this one. Finally realising the art of underpromising and over delivering.

Hand on head emoji

We need to know how much the HCV revenues are bringing in. That market is playing catch up aggressively post everything being covid, but as always clarity is needed.

Unicef, dispute resolution and post covid opportunity? I do like Nova. Spending lots of cash, not sure on their current cash position. Not knocking it, it's doing a very good job keeping the NHS safe.

Well a PHE contract worth £4.7m has just added £75m to Novacyt's market cap in 3 days. Wonder how long it will take for the buffer validation to come through for GDR? CE marking has popped up 2 months early so ahead of the game for once there.

*stiched

Commercial development. The product itself is ready. Hopefully the PHE will go for it post validation of the buffer. Novacyt was just awarded a contract after being stocked up. Government need to show support for UK diagnostics. I know Budd is in love with the USA but big op here for POC, especially one getting 100% on all 4 scores.

Because CE mark is one thing, PHE is validating the biosafety of GDR's exclusive buffer method which is something else, otherwise it wouldn't be CE marked yet and hence the reason for clarity from the company paid with our money to, you know, clarify.

Thanks.

Please can someone repost this for me. I think it was to do with being referred back to the website rather than answering the question.

@rbr08 my opinion is they def should of RNS'd it. They have a very arrogant attitude in this respect. Would have done wonders for sentiment being this far ahead of schedule for once rather than all this 3 months bu11s2it

Not common knowledge, I said in public domain. Don't switch my words around Dave aka Guy. Cheers.